LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 6 of 15: End-point mean cell counts and mean normalized growth rate inhibition values for biological replicate 3. - Dataset (ID:20314)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Mean Total Cell Count Before Treatment Mean Total Cell Count After Treatment Mean Total Control Cell Count Mean Relative Cell Count Mean Normalized Growth Rate Inhibition Value
MCF 10A-H2B-mCherry Palbociclib
0.0033333
 95.70 27.76 8602 6712 1.2815 0.9824
MCF 10A-H2B-mCherry Etoposide
0.018333
 2.30 56.33 324 255 1.2870 0.6703
MCF 10A-H2B-mCherry Etoposide
0.0010833
 95.70 27.76 8661 6712 1.2903 0.9277
MCF 10A-H2B-mCherry Vorinostat
0.01
 95.70 27.76 8684 6712 1.2938 1.0076
MCF 10A-H2B-mCherry Palbociclib
0.17783
 2.30 56.33 324 255 1.2952 0.5952
MCF 10A-H2B-mCherry Trametinib
0.0016667
 17.60 56.33 1123 868 1.2979 0.9858
MCF 10A-H2B-mCherry Alpelisib
0.01
 95.70 27.76 8717 6712 1.2987 0.9937
MCF 10A-H2B-mCherry Neratinib
0.00043333
 95.70 27.76 8720 6712 1.2991 0.9699
MCF 10A-H2B-mCherry Etoposide
0.17783
 2.30 56.33 327 255 1.3032 0.6110
MCF 10A-H2B-mCherry Neratinib
0.17783
 2.30 56.33 327 255 1.3078 0.6228
MCF 10A-H2B-mCherry Trametinib
0.0016667
 14.20 56.33 826 634 1.3092 0.9648
MCF 10A-H2B-mCherry Trametinib
0.0016667
 2.30 56.33 335 255 1.3342 0.6299
MCF 10A-H2B-mCherry Trametinib
0.0016667
 15.90 56.33 967 726 1.3358 0.9953
MCF 10A-H2B-mCherry Neratinib
3.1623
 2.30 56.33 342 255 1.3397 0.7139
MCF 10A-H2B-mCherry Etoposide
0.0010833
 2.30 56.33 334 255 1.3456 0.6199
MCF 10A-H2B-mCherry Trametinib
1
 2.30 56.33 347 255 1.3628 0.6837
MCF 10A-H2B-mCherry Neratinib
0.56234
 2.30 56.33 365 255 1.4478 0.7424